• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年早期致动脉粥样硬化脂质累积暴露的预测

Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood.

作者信息

Wilkins John T, Ning Hongyan, Allen Norrina B, Zheutlin Alexander, Shah Nilay S, Feinstein Matthew J, Perak Amanda M, Khan Sadiya S, Bhatt Ankeet S, Shah Ravi, Murthy Venkatesh, Sniderman Allan, Lloyd-Jones Donald M

机构信息

Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Preventive Medicine (Epidemiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Department of Preventive Medicine (Epidemiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

出版信息

J Am Coll Cardiol. 2024 Sep 10;84(11):961-973. doi: 10.1016/j.jacc.2024.05.070.

DOI:10.1016/j.jacc.2024.05.070
PMID:39232632
Abstract

BACKGROUND

The ability of a 1-time measurement of non-high-density lipoprotein cholesterol (non-HDL-C) or low-density lipoprotein cholesterol (LDL-C) to predict the cumulative exposure to these lipids during early adulthood (age 18-40 years) and the associated atherosclerotic cardiovascular disease (ASCVD) risk after age 40 years is not clear.

OBJECTIVES

The objectives of this study were to evaluate whether a 1-time measurement of non-HDL-C or LDL-C in a young adult can predict cumulative exposure to these lipids during early adulthood, and to quantify the association between cumulative exposure to non-HDL-C or LDL-C during early adulthood and the risk of ASCVD after age 40 years.

METHODS

We included CARDIA (Coronary Artery Risk Development in Young Adults Study) participants who were free of cardiovascular disease before age 40 years, were not taking lipid-lowering medications, and had ≥3 measurements of LDL-C and non-HDL-C before age 40 years. First, we assessed the ability of a 1-time measurement of LDL-C or non-HDL-C obtained between age 18 and 30 years to predict the quartile of cumulative lipid exposure from ages 18 to 40 years. Second, we assessed the associations between quartiles of cumulative lipid exposure from ages 18 to 40 years with ASCVD events (fatal and nonfatal myocardial infarction and stroke) after age 40 years.

RESULTS

Of 4,104 CARDIA participants who had multiple lipid measurements before and after age 30 years, 3,995 participants met our inclusion criteria and were in the final analysis set. A 1-time measure of non-HDL-C and LDL-C had excellent discrimination for predicting membership in the top or bottom quartiles of cumulative exposure (AUC: 0.93 for the 4 models). The absolute values of non-HDL-C and LDL-C that predicted membership in the top quartiles with the highest simultaneous sensitivity and specificity (highest Youden's Index) were >135 mg/dL for non-HDL-C and >118 mg/dL for LDL-C; the values that predicted membership in the bottom quartiles were <107 mg/dL for non-HDL-C and <96 mg/dL for LDL-C. Individuals in the top quartile of non-HDL-C and LDL-C exposure had demographic-adjusted HRs of 4.6 (95% CI: 2.84-7.29) and 4.0 (95% CI: 2.50-6.33) for ASCVD events after age 40 years, respectively, when compared with each bottom quartile.

CONCLUSIONS

Single measures of non-HDL-C and LDL-C obtained between ages 18 and 30 years are highly predictive of cumulative exposure before age 40 years, which in turn strongly predicts later-life ASCVD events.

摘要

背景

单次测量非高密度脂蛋白胆固醇(non-HDL-C)或低密度脂蛋白胆固醇(LDL-C)能否预测成年早期(18 - 40岁)这些脂质的累积暴露情况以及40岁后相关的动脉粥样硬化性心血管疾病(ASCVD)风险尚不清楚。

目的

本研究的目的是评估在年轻成年人中单次测量non-HDL-C或LDL-C能否预测成年早期这些脂质的累积暴露情况,并量化成年早期non-HDL-C或LDL-C的累积暴露与40岁后ASCVD风险之间的关联。

方法

我们纳入了CARDIA(年轻成年人冠状动脉风险发展研究)的参与者,这些参与者在40岁之前无心血管疾病,未服用降脂药物,且在40岁之前有≥3次LDL-C和non-HDL-C测量值。首先,我们评估在18至30岁之间获得的单次LDL-C或non-HDL-C测量值预测18至40岁累积脂质暴露四分位数的能力。其次,我们评估18至40岁累积脂质暴露四分位数与40岁后ASCVD事件(致命和非致命心肌梗死及中风)之间的关联。

结果

在4104名30岁前后进行多次脂质测量的CARDIA参与者中,3995名参与者符合我们的纳入标准并纳入最终分析集。单次测量non-HDL-C和LDL-C在预测累积暴露的上四分位数或下四分位数归属方面具有出色的辨别能力(4个模型的AUC:0.93)。预测上四分位数归属且同时具有最高灵敏度和特异性(最高约登指数)的non-HDL-C和LDL-C绝对值分别为non-HDL-C >135 mg/dL和LDL-C >118 mg/dL;预测下四分位数归属的值分别为non-HDL-C <107 mg/dL和LDL-C <96 mg/dL。与每个下四分位数相比,non-HDL-C和LDL-C暴露上四分位数的个体在40岁后发生ASCVD事件的经人口统计学调整的HR分别为4.6(95%CI:2.

相似文献

1
Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood.成年早期致动脉粥样硬化脂质累积暴露的预测
J Am Coll Cardiol. 2024 Sep 10;84(11):961-973. doi: 10.1016/j.jacc.2024.05.070.
2
Cumulative exposure to atherogenic lipoprotein particles in young adults and subsequent incident atherosclerotic cardiovascular disease.年轻成年人中致动脉粥样硬化脂蛋白颗粒的累积暴露与随后发生的动脉粥样硬化性心血管疾病
Eur Heart J. 2025 Jul 4. doi: 10.1093/eurheartj/ehaf472.
3
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.糖尿病护理质量改进策略:对成年糖尿病患者结局的影响。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513.
4
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.用于预防动脉粥样硬化性心血管疾病的固定剂量联合疗法。
Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD009868. doi: 10.1002/14651858.CD009868.pub3.
5
Non-high-density lipoprotein cholesterol outperforms low-density lipoprotein cholesterol in predicting cardiovascular events among high-risk Asians.在预测高危亚洲人心血管事件方面,非高密度脂蛋白胆固醇比低密度脂蛋白胆固醇表现更优。
J Clin Lipidol. 2025 May-Jun;19(3):554-562. doi: 10.1016/j.jacl.2025.01.002. Epub 2025 Jan 19.
6
Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD: The VICTORION-Mono Randomized Clinical Trial.inclisiran单药治疗在无动脉粥样硬化性心血管疾病(ASCVD)患者中的安全性和降脂疗效:VICTORION-Mono随机临床试验
J Am Coll Cardiol. 2025 Jul 22;86(3):196-208. doi: 10.1016/j.jacc.2025.04.049. Epub 2025 May 5.
7
Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification.有无种族分层情况下动脉粥样硬化性心血管疾病的风险预测
JAMA Cardiol. 2024 Jan 1;9(1):55-62. doi: 10.1001/jamacardio.2023.4520.
8
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.脂蛋白吸附治疗起始于儿童期的纯合子家族性高胆固醇血症患者的心血管结局:来自两个登记处的国际队列的长期随访。
Lancet Child Adolesc Health. 2024 Jul;8(7):491-499. doi: 10.1016/S2352-4642(24)00073-7. Epub 2024 May 14.
9
Lipid-lowering efficacy of atorvastatin.阿托伐他汀的降脂疗效。
Cochrane Database Syst Rev. 2015 Mar 12;2015(3):CD008226. doi: 10.1002/14651858.CD008226.pub3.
10
Comprehensive meta-analysis of the effects of oral medroxyprogesterone acetate plus conjugated equine oestrogens on the lipid profile in women: Insights from randomized controlled trials.口服醋酸甲羟孕酮联合结合型马雌激素对女性血脂谱影响的综合荟萃分析:来自随机对照试验的见解。
Eur J Clin Invest. 2024 Aug;54(8):e14211. doi: 10.1111/eci.14211. Epub 2024 May 10.

引用本文的文献

1
Association of cardiovascular risks and carotid stiffening at ultrafast ultrasound imaging in young populations.年轻人群中超快超声成像下心血管风险与颈动脉僵硬度的关联
Eur Radiol. 2025 Sep 8. doi: 10.1007/s00330-025-11979-2.
2
Association of Cardiovascular Health and Time Lived With Zero Coronary Artery Calcium.心血管健康与无冠状动脉钙化生存时间的关联
JACC Cardiovasc Imaging. 2025 Jul 15. doi: 10.1016/j.jcmg.2025.05.022.
3
Portfolio diet and LDL-C in a young, multiethnic cohort: cross-sectional analyses with cumulative exposure modeling.
年轻多民族队列中的组合饮食与低密度脂蛋白胆固醇:采用累积暴露模型的横断面分析
BMC Public Health. 2025 May 13;25(1):1761. doi: 10.1186/s12889-025-22479-9.
4
Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management.慢性炎症性疾病与心血管风险:当前见解及优化管理的未来策略
Int J Mol Sci. 2025 Mar 27;26(7):3071. doi: 10.3390/ijms26073071.
5
NLRP3 inflammasome in cardiovascular diseases: an update.心血管疾病中的NLRP3炎性小体:最新进展
Front Immunol. 2025 Feb 26;16:1550226. doi: 10.3389/fimmu.2025.1550226. eCollection 2025.